BOOM

Trending Searches

    SUPPORT
    BOOM

    Trending News

      • Fact Check 
        • Fast Check
        • Politics
        • Business
        • Entertainment
        • Social
        • Sports
        • World
      • Law
      • Explainers
      • News 
        • All News
      • Decode 
        • Impact
        • Scamcheck
        • Life
        • Voices
      • Media Buddhi 
        • Digital Buddhi
        • Senior Citizens
        • Videos
      • Web Stories
      • BOOM Research
      • BOOM Labs
      • Deepfake Tracker
      • Videos 
        • Facts Neeti
      • Home-icon
        Home
      • About Us-icon
        About Us
      • Authors-icon
        Authors
      • Team-icon
        Team
      • Careers-icon
        Careers
      • Internship-icon
        Internship
      • Contact Us-icon
        Contact Us
      • Methodology-icon
        Methodology
      • Correction Policy-icon
        Correction Policy
      • Non-Partnership Policy-icon
        Non-Partnership Policy
      • Cookie Policy-icon
        Cookie Policy
      • Grievance Redressal-icon
        Grievance Redressal
      • Republishing Guidelines-icon
        Republishing Guidelines
      • Fact Check-icon
        Fact Check
        Fast Check
        Politics
        Business
        Entertainment
        Social
        Sports
        World
      • Law-icon
        Law
      • Explainers-icon
        Explainers
      • News-icon
        News
        All News
      • Decode-icon
        Decode
        Impact
        Scamcheck
        Life
        Voices
      • Media Buddhi-icon
        Media Buddhi
        Digital Buddhi
        Senior Citizens
        Videos
      • Web Stories-icon
        Web Stories
      • BOOM Research-icon
        BOOM Research
      • BOOM Labs-icon
        BOOM Labs
      • Deepfake Tracker-icon
        Deepfake Tracker
      • Videos-icon
        Videos
        Facts Neeti
      Trending Tags
      TRENDING
      • #Operation Sindoor
      • #Pahalgam Terror Attack
      • #Narendra Modi
      • #Rahul Gandhi
      • #Waqf Amendment Bill
      • #Arvind Kejriwal
      • #Deepfake
      • #Artificial Intelligence
      • Home
      • Coronavirus
      • COVID-19 Vaccine For Above 50 Could...
      Coronavirus

      COVID-19 Vaccine For Above 50 Could Be Rolled Out In March

      The government has still not decided whether the cost for the vaccine shots will be borne by the government or the recipients

      By - Shachi Sutaria |
      Published -  16 Feb 2021 4:32 PM IST
    • Boomlive
      COVID-19 Vaccine For Above 50 Could Be Rolled Out In March

      Health Union Minister Dr. Harsh Vardhan in a press conference on Monday announced that the COVID-19 vaccine will be made available to the 27 crore citizens above the age of 50 in two or three weeks. Currently, Covishield and Covaxin is only being administered to the three-crore health and frontline workers of which only close to 87 lakhs have been vaccinated.

      Even though the government has been bearing the cost of vaccinating the health and frontline workers, there is less clarity on who will be bearing the costs for vaccinating 27 crore people above the age of 50.

      "An internal committee of experts is deliberating on this decision of how the vaccines will be distributed and paid for. We will discuss this in our weekly COVID-19 press conferences once a decision is finalised," stated the health minister

      Each recipient is expected to be administered two shots of the vaccine in a period of 28 days. In the Union Budget for the year 2021-2022, the government has allocated ₹35,000 crore to COVID-19 distribution and intends to allocate more if required, Finance Minister Nirmala Sitharaman stated.

      If the government decides that the cost of the vaccines will be borne by the recipients, it is important to know how much each vaccine will cost.

      Adar Poonawalla, CEO of Serum Institute of India, producer of Covishield has stated in several interviews that the vaccine manufacturer intends to sell the vaccine for ₹200-250 to the government, and when permitted to sell in the market, it will sell the vaccine for close to ₹1,000 per shot. If the government intends to continue vaccination at its centres, and not pay for vaccinating the 27 crore citizens, each citizen may have to pay close to ₹400-500 for receiving the vaccine.

      If purchased off the shelves the citizens may have to shell out close to ₹2,000 for receiving the vaccine and another fee to pay the health workers who administer it to them.

      The Indian government procured Covaxin indigenously produced by Bharat Biotech at ₹206 per dose while the marketed price is ₹295. As Bharat Biotech supplied close to 16.5 lakh doses for free, the value of each dose procured by the government decreased. The actual price at which Bharat Biotech intends to sell the vaccine to the private players has not yet been announced.

      Citizens will have to wait for the government to take a final call on the costing and distribution of the vaccines. Experts believe that if the vaccine is not administered for free, it may affect the uptake of the vaccine.

      Also Read:Centre To Use Electoral Roll To Identify Who Receives COVID-19 Vaccine

      Along with the already approved two vaccines, Russia's Sputnik vaccine and Zydus' Zync-CoV-D vaccine are in final stages of trials and could receive emergency use authorisation from the Central Drugs Standard and Control Organisation, the apex body in the country.

      Also Read:COVID-19 Vaccine: What Are The Expected Side Effects



      Tags

      astrazeneca vaccineCOVID-19
      Read Full Article
      Next Story
      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker. Please reload after ad blocker is disabled.
      X

      Subscribe to BOOM Newsletters

      👉 No spam, no paywall — but verified insights.

      Please enter a Email Address
      Subscribe for free!

      Stay Ahead of Misinformation!

      Please enter a Email Address
      Subscribe Now🛡️ 100% Privacy Protected | No Spam, Just Facts
      By subscribing, you agree with the Terms & conditions and Privacy Policy connected to the offer

      Thank you for subscribing!

      You’re now part of the BOOM community.

      Or, Subscribe to receive latest news via email
      Subscribed Successfully...
      Copy HTMLHTML is copied!
      There's no data to copy!